Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Pathogens (Basel, Switzerland)|March 26, 2025
Improving HCV Screening in Addiction Care Centers with Plasma Separation CardsFernando Velásquez Orozco, David Tabernero, María Gabriela Barbaglia, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 6, 2022
Emergence of Delta and Omicron variants carrying resistance-associated mutations in immunocompromised patients undergoing sotrovimab treatment with long-term viral excretionCristina Andrés, Alejandra González-Sánchez, Moraima Jiménez, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Assessing Liver Fibrosis Using the FIB4 Index in the Community SettingAlbert Blanco-Grau, Pablo Gabriel-Medina, Francisco Rodriguez-Algarra, et al.
The Journal of Infection|April 30, 2026
Early antiretroviral therapy shapes the immunometabolic landscape without reducing the intact HIV reservoirPaula Suanzes, Judith Grau-Expósito, Jordi Navarro, et al.
Therapeutic Advances in Gastroenterology|September 2, 2021
Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized managementLara Grau-López, Cristina Marcos-Fosch, Constanza Daigre, et al.
The American Journal of Tropical Medicine and Hygiene|July 24, 2019
Treatment Outcomes and Adverse Events from a Standardized Multidrug-Resistant Tuberculosis Regimen in a Rural Setting in AngolaMaría Luisa Aznar, Ariadna Rando Segura, María Milagros Moreno, et al.
International Journal of Molecular Sciences|December 23, 2023
In-Host HEV Quasispecies Evolution Shows the Limits of Mutagenic Antiviral TreatmentsSergi Colomer-Castell, Josep Gregori, Damir Garcia-Cehic, et al.
World Journal of Gastroenterology|June 12, 2020
Conservation and variability of hepatitis B core at different chronic hepatitis stagesMarçal Yll, Maria Francesca Cortese, Mercedes Guerrero-Murillo, et al.
Neurology|January 17, 2025
Effect of the Number of Vaccine Doses Before Starting Anti-CD20 Therapy on Seroprotection Rates Against Hepatitis B Virus in People With MSRené Carvajal, David Guananga-Álvarez, Carmen Tur, et al.
Biomedicines|May 28, 2022
Hepatitis B Virus Variants with Multiple Insertions and/or Deletions in the X Open Reading Frame 3' End: Common Members of Viral Quasispecies in Chronic Hepatitis B PatientsSelene García-García, Andrea Caballero-Garralda, David Tabernero, et al.
Pageof 9